SUSTAINING OPERATIONS FACILITY, MSD CARLOW

SUSTAINING OPERATIONS FACILITY, MSD CARLOW

SUSTAINING OPERATIONS FACILITY, MSD CARLOW

PJ Hegarty has a strong professional relationship with pharmaceutical company Merck, Sharpe & Dome, which produces vaccines and cancer medication for markets worldwide.

Client : MSD International FMBH
Service : Pharma/hi-tech
Architect : RKD
Quantity surveyors : N/A
Structural engineer : Punch Consulting Engineers
Services engineer : Malachy Walsh & Partners
Value : €5.6 million

We constructed the original plant in 2008, and later led an expansion to incorporate a new Vaccine and Biologics Sterile Facility, which won in the Operational Excellence category at the International Society for Pharmaceutical Engineering Facility of the Year Awards 2013. In a subsequent project, we were contracted to develop a new Sustaining Operation Facility for MSD.

The project included the design and build of a 2,068m² one- and two-storey building and ancillary site works. The ground floor of the new facility includes a staff canteen and commercial kitchen, seminar rooms and ancillary support spaces. First floor facilities are taken up by office spaces, including meeting rooms and ancillary support spaces.

Site works included connections to existing utilities, general landscaping and paved areas within the site boundary and ancillary site works. The two-storey element of the building features air handling units and associated mechanical equipment within a screened open top enclosure.